VPS9D1-AS1

Across TCGA pan-cancer cohorts, VPS9D1-AS1 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of VPS9D1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where VPS9D1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VPS9D1-AS1 is over-expressed in tumor.

COAD, STAD, and HNSC are the cancer types where VPS9D1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VPS9D1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+2.380	<.001	11	view →
STAD	All	IV	+2.683	<.001	10	view →
HNSC	Male	All	+1.603	<.001	10	view →
LUAD	Male	II,III,IV	+1.906	<.001	9	view →
LUSC	Female	II,III,IV	+3.004	<.001	8	view →
READ	All	All	+1.826	<.001	7	view →
UCEC	All	All	+1.940	<.001	6	view →
BLCA	All	All	+1.251	.003	6	view →
CHOL	Male	All	+2.656	<.001	4	view →
LIHC	All	All	+0.529	.001	4	view →
KIRC	Male	All	+0.313	.001	3	view →
PRAD	All	All	+1.672	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

VPS9D1-AS1–COAD

Open the COAD breakdown →